Save Seven Year Old Josh Hardy.

  • al: Terry Morrell
  • destinatario: Kenneth Moch, president and CEO of Chimerix

Seven year old Josh Hardy is in desperate need of a drug called Brincidofovir, an antiviral drug that has been fourteen years in the making and has recieved over 72 million in Federal Funding. The doctors believe this drug could save Josh's life but the company, Chimerix won't provide it. The company says that the drug is still in the trial phase and if they provide the the drug to Josh Hardy now it would hamper their efforts to get it approved.The company had been releasing the breakthrough antiviral drug for compassionate use to patients like Josh until two years ago when they decided that it was slowing down their research and decide to focus soley on getting the drug approved.

firma la petición
firma la petición
Has deshabilitado JavaScript. Sin este programa, puede que nuestro sitio no funcione debidamente.

política de privacidad

al firmar, aceptas los condiciones del servicio de Care2
Puede administrar sus suscripciones por correo electrónico en cualquier momento.

¿Tienes dificultades para firmarla?? Infórmanos.